A nano-innate immune system activator for cancer therapy in a 4T1 tumor-bearing mouse model

BACKGROUND: Harnessing the immune system to fight cancer has led to prominent clinical successes. Strategies to stimulate innate immune effectors are attracting considerable interest in cancer therapy. Here, through conjugating multivalent Fc fragments onto the surface of mesoporous silica nanoparti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiang-Yu, Zhu, Mao-Hua, Wang, Xiao-Yu, Dong, Xiao, Liu, Hai-Jun, Li, Rui-Yang, Jia, Shi-Chong, Lu, Qin, Zhao, Mei, Sun, Peng, Chen, Hong-Zhuan, Fang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800325/
https://www.ncbi.nlm.nih.gov/pubmed/35093074
http://dx.doi.org/10.1186/s12951-022-01265-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800325/
https://www.ncbi.nlm.nih.gov/pubmed/35093074
http://dx.doi.org/10.1186/s12951-022-01265-4

Ejemplares similares